Skip to main content
Zipei Feng, MD, Otolaryngology (ENT), Portland, OR

ZipeiFengMDPhD

Otolaryngology (ENT) Portland, OR

Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery, Head & Neck Plastic Surgery

Physician

Dr. Feng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Feng's full profile

Already have an account?

  • Office

    The Oregon Clinic ENT West
    9155 SW Barnes Rd Suite 536
    Portland, OR 97225
    Phone+1 503-935-8100
    Fax+1 503-935-8110

Summary

  • Dr. Zipei Feng is an otolaryngologist in Portland, OR and is affiliated with The Oregon Clinic. He received his medical degree from Oregon Health and Science University School of Medicine. He completed his residency in Otolaryngology Head Neck Surgery at Baylor College of Medicine, and subsequently fellowship in Head Neck Surgery and Microvascular Reconstruction at Stanford University Medical Center. He specializes in head neck microvascular surgery and head neck oncologic surgery. He has more than 25 publications and over 1000 citings.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2023 - 2024
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2018 - 2023
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 2015

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2023 - 2025
  • OR State Medical License
    OR State Medical License 2024 - 2025

Publications & Presentations

PubMed

Journal Articles

  • Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma  
    Brett Sheppard, Charles D Lopez, Zipei Feng, Clinical Cancer Research

Books/Book Chapters